Back
BridgeBio Pharma, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
68
BBIO
BridgeBio Pharma, Inc.
Last Price:
$79.17
Seasonality Move:
5.42%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atBridgeBio Pharma, Inc. Stock Forecast
-
Over the next 52 weeks, BridgeBio Pharma, Inc. has on average historically risen by 85.9% based on the past 6 years of stock performance.
-
BridgeBio Pharma, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is BridgeBio Pharma, Inc. Stock Undervalued?The current BridgeBio Pharma, Inc. [BBIO] share price is $79.11. The Score for BBIO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
BBIO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will BridgeBio Pharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BridgeBio Pharma, Inc. has on average historically risen by 85.9% based on the past 6 years of stock performance.
BridgeBio Pharma, Inc. Stock Rating
Buy
68
BridgeBio Pharma, Inc. (BBIO)
is a Buy
Is BridgeBio Pharma, Inc. overpriced?
-
BridgeBio Pharma, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
BridgeBio Pharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com
52-Week Data
52-Week High:
79.88
52-Week Low:
28.33
Prediction Charts
Market Cap:
15.2B
Price in USD:
79.11
Volume:
2.6M
Beta:
1.05
Technical Analysis
SMA50:
71.00
SMA100:
62.16
SMA200:
51.06
52-Wk Change:
134.54%
Stock Predictions
-
Is BridgeBio Pharma, Inc. stock public?Yes, BridgeBio Pharma, Inc. is a publicly traded company.
-
What is the BridgeBio Pharma, Inc. stock quote today?The BridgeBio Pharma, Inc. stock price is 79.11 USD today.
-
How to buy BridgeBio Pharma, Inc. stock online?You can buy BridgeBio Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-22 | 76.80 | 77.09 | 78.44 | 76.45 |
| Dec-23 | 76.38 | 76.40 | 77.40 | 75.82 |
| Dec-24 | 76.77 | 76.53 | 77.32 | 76.38 |
| Dec-26 | 76.80 | 75.80 | 77.48 | 75.60 |
| Dec-29 | 75.04 | 75.61 | 75.84 | 74.53 |
| Dec-30 | 75.57 | 75.48 | 75.91 | 74.47 |
| Dec-31 | 75.50 | 76.49 | 77.28 | 74.99 |
| Jan-5 | 78.29 | 73.42 | 78.59 | 71.99 |
| Jan-6 | 73.69 | 73.99 | 74.29 | 71.19 |
| Jan-7 | 74.13 | 74.27 | 75.57 | 72.89 |
| Jan-8 | 73.55 | 73.82 | 75.49 | 73.05 |
| Jan-9 | 74.48 | 77.25 | 78.36 | 74.46 |
| Jan-12 | 76.78 | 76.84 | 77.41 | 70.95 |
| Jan-13 | 76.15 | 79.11 | 79.88 | 75.07 |
BridgeBio Pharma, Inc. Earnings
BridgeBio Pharma, Inc. Earnings Report: Per Share BridgeBio Pharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BridgeBio Pharma, Inc. Forecast Revenue Growth
BridgeBio Pharma, Inc. Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.42 per share, and an increase next year of $2.60 per share.
* BridgeBio Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.